EconPapers    
Economics at your fingertips  
 

The Balanced Survivor Average Causal Effect

Greene Tom (), Joffe Marshall (), Hu Bo (), Li Liang () and Boucher Ken ()
Additional contact information
Greene Tom: Division of Epidemiology, Department of Internal Medicine, University of Utah
Joffe Marshall: Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA, United States
Hu Bo: Department of Quantitative Health Sciences, Cleveland Clinic, OH, United States
Li Liang: Department of Quantitative Health Sciences, Cleveland Clinic, OH, United States
Boucher Ken: Department of Oncological Sciences, University of Utah, UT, United States

The International Journal of Biostatistics, 2013, vol. 9, issue 2, 291-306

Abstract: Abstract: Statistical analysis of longitudinal outcomes is often complicated by the absence of observable values in patients who die prior to their scheduled measurement. In such cases, the longitudinal data are said to be “truncated by death” to emphasize that the longitudinal measurements are not simply missing, but are undefined after death. Recently, the truncation by death problem has been investigated using the framework of principal stratification to define the target estimand as the survivor average causal effect (SACE), which in the context of a two-group randomized clinical trial is the mean difference in the longitudinal outcome between the treatment and control groups for the principal stratum of always-survivors. The SACE is not identified without untestable assumptions. These assumptions have often been formulated in terms of a monotonicity constraint requiring that the treatment does not reduce survival in any patient, in conjunction with assumed values for mean differences in the longitudinal outcome between certain principal strata. In this paper, we introduce an alternative estimand, the balanced-SACE, which is defined as the average causal effect on the longitudinal outcome in a particular subset of the always-survivors that is balanced with respect to the potential survival times under the treatment and control. We propose a simple estimator of the balanced-SACE that compares the longitudinal outcomes between equivalent fractions of the longest surviving patients between the treatment and control groups and does not require a monotonicity assumption. We provide expressions for the large sample bias of the estimator, along with sensitivity analyses and strategies to minimize this bias. We consider statistical inference under a bootstrap resampling procedure.

Keywords: longitudinal analysis; truncation by death; randomized trial (search for similar items in EconPapers)
Date: 2013
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://doi.org/10.1515/ijb-2012-0013 (text/html)
For access to full text, subscription to the journal or payment for the individual article is required.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:bpj:ijbist:v:9:y:2013:i:2:p:291-306:n:1

Ordering information: This journal article can be ordered from
https://www.degruyter.com/journal/key/ijb/html

DOI: 10.1515/ijb-2012-0013

Access Statistics for this article

The International Journal of Biostatistics is currently edited by Antoine Chambaz, Alan E. Hubbard and Mark J. van der Laan

More articles in The International Journal of Biostatistics from De Gruyter
Bibliographic data for series maintained by Peter Golla ().

 
Page updated 2025-03-19
Handle: RePEc:bpj:ijbist:v:9:y:2013:i:2:p:291-306:n:1